« Back to Record
Citation APA

Fumagalli, D., Salgado, R., Criscitiello, C., Pugliano, L., Laïos, I., Wilson, T. A., Larsimont, D., Piccart-Gebhart, M., Michiels, S., Lackner, L., Sotiriou, C., & Loi, S. (2013). Use of mutational profiling of metastatic ER+/HER2- breast cancers and the coexistence of KRAS, MET, BRAF, and FGFR3 with PIK3CA mutations. J Clin Oncol. Vol. 31 (suppl; abstr 11003) Abstract session presented at ASCO Annual meeting(May 31, June 4, 2013: Chicago, IL, USA).


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/157845

Fumagalli, D., Salgado, R., Criscitiello, C., Pugliano, L., Laïos, I., Wilson, T. A., Larsimont, D., Piccart-Gebhart, M., Michiels, S., Lackner, L., Sotiriou, C., & Loi, S. (2013). Use of mutational profiling of metastatic ER+/HER2- breast cancers and the coexistence of KRAS, MET, BRAF, and FGFR3 with PIK3CA mutations. J Clin Oncol. Vol. 31 (suppl; abstr 11003) Abstract session presented at ASCO Annual meeting(May 31, June 4, 2013: Chicago, IL, USA).